Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy

Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study

(2023) Yong‐Wen Leow et al.   JOURNAL OF VIRAL HEPATITIS

Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease

(2022) Wah‐Kheong Chan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Meaning of non‐overlapping patients between the MAFLD and NAFLD definitions

(2022) Wah‐Kheong Chan et al.   LIVER INTERNATIONAL

Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?

(2022) Zobair M. Younossi et al.   HEPATOLOGY

Epidemiological trends of Gastrointestinal and Liver Diseases in Malaysia: a single‐center observational study

(2022) Sze Zee Lim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Comparison between obese and non-obese NAFLD

(2022) Wah-Kheong Chan   Clinical and Molecular Hepatology

On the proposed definition of metabolic associated fatty liver disease

(2021) Vincent Wai-Sun Wong et al.   Clinical Gastroenterology and Hepatology

Endorsing the redefinition of fatty liver disease

(2021) Soek Siam Tan et al.   Lancet Gastroenterology & Hepatology

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease

(2021) Jiaofeng Huang et al.   Risk Management and Healthcare Policy

Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: The rotterdam study

(2021) Laurens van Kleef et al.   HEPATOLOGY

2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis

(2021) Michael H. Le et al.   Clinical Gastroenterology and Hepatology

Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality?

(2021) Xu Chen et al.   JOURNAL OF HEPATOLOGY

Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups

(2021) Ibrahim Ayada et al.   LIVER INTERNATIONAL

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study

(2021) Eunice Xiang-Xuan Tan et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

(2021) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Modelling NAFLD disease burden in four Asian regions-2019-2030

(2020) Chris Estes et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

(2020) Rod S. Taylor et al.   GASTROENTEROLOGY

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

(2020) Philip N Newsome et al.   Lancet Gastroenterology & Hepatology

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

(2020) Giovanni Targher et al.   GUT

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

2020 International Society of Hypertension Global Hypertension Practice Guidelines

(2020) Thomas Unger et al.   HYPERTENSION

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   Hepatology International

Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis

(2019) Wah-Kheong Chan et al.   Clinical Gastroenterology and Hepatology

Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease

(2019) Stanley Khoo et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

(2019) Jie Li et al.   Lancet Gastroenterology & Hepatology

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

(2017) Vincent Wai-Sun Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease

(2017) Say-Yee Loo et al.   HEPATOBILIARY SURGERY AND NUTRITION

Noninvasive fatty liver markers predict liver disease mortality in the U.S. population

(2016) Aynur Unalp-Arida et al.   HEPATOLOGY

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Liver cancer in Malaysia: Epidemiology and clinical presentation in a multiracial Asian population

(2015) Khean-Lee Goh et al.   Journal of Digestive Diseases

A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis

(2014) Wah-Kheong Chan et al.   Hepatology International

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

(2013) Robert J. Wong et al.   HEPATOLOGY

Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia

(2012) Seok-Chin Goh et al.   Hepatology International